Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 04, 2025

Get In Touch

Obesity Discussions to Take Spotlight at RSSDI 2025; Experts to Delve into Tirzepatide's Dual Agonism in Metabolic Care Diabetes and Endocrinology

Obesity Discussions to Take Spotlight at RSSDI 2025; Experts to Delve into Tirzepatide's Dual Agonism in Metabolic Care

  • 04 November 2025
  • 4 hours from now

Eli Lilly's Diabetes Drug Mounjaro Gets Second Brand Yurpeak via Cipla Deal Pharma News

Eli Lilly's Diabetes Drug Mounjaro Gets Second Brand Yurpeak via Cipla Deal

  • 24 October 2025
  • 1 week ago

CDSCO Panel Clears Eli Lilly's Tirzepatide for Phase IV Clinical Trial in India Pharma News

CDSCO Panel Clears Eli Lilly's Tirzepatide for Phase IV Clinical Trial in India

  • 21 October 2025
  • 1 week ago

Rs 233 Crore in 6 Months: Mounjaro Becomes India's Second-Biggest Drug by Sales Pharma News

Rs 233 Crore in 6 Months: Mounjaro Becomes India's Second-Biggest Drug by Sales

  • 10 October 2025
  • 3 weeks ago

Tirzepatide Improved Outcomes in Patients with Both Atrial Fibrillation and COPD: Study Cardiology and CTVS

Tirzepatide Improved Outcomes in Patients with Both Atrial Fibrillation and COPD: Study

  • 04 October 2025
  • 4 weeks ago

Tirzepatide Improves Blood Sugar Control in Children With Type 2 Diabetes: SURPASS-PEDS Trial Diabetes and Endocrinology

Tirzepatide Improves Blood Sugar Control in Children With Type 2 Diabetes: SURPASS-PEDS Trial

  • 20 September 2025
  • 1 month ago

Tirzepatide and Thiazide Use in CKD Linked to Risk of Severe Hypercalcemia, Reveals Case Report Diabetes and Endocrinology

Tirzepatide and Thiazide Use in CKD Linked to Risk of Severe Hypercalcemia, Reveals Case Report

  • 16 September 2025
  • 1 month ago

Tirzepatide- A novel therapeutic against metabolic dysfunction-associated steatotic liver disease, reports research Gastroenterology

Tirzepatide- A novel therapeutic against metabolic dysfunction-associated steatotic liver disease, reports research

  • 13 September 2025
  • 1 month ago

EMA warns of sharp rise in illegal medicines sold in EU Diabetes and Endocrinology

EMA warns of sharp rise in illegal medicines sold in EU

  • 09 September 2025
  • 1 month ago

Tirzepatide Significantly Lowers Albuminuria Across All Administered Doses In Patients With Type 2 Diabetes: Study Nephrology

Tirzepatide Significantly Lowers Albuminuria Across All Administered Doses In Patients With Type 2 Diabetes: Study

  • 27 July 2025
  • 3 months ago

Recent News

Study Reveals Citrus and Grape Compounds May Help...

  • 04 November, 2025

What Your Neck Size Says About Your Heart Health?...

  • 04 November, 2025

EVOQUE TTVR Delivers Promising Real-World Results:...

  • 04 November, 2025

Influenza Vaccination Reduces Mortality and Readmi...

  • 04 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.